Evidence map›Paper›PMID 28928373›Full record

ArticleScientific reports2017

A synthetic cell permeable antioxidant protects neurons against acute oxidative stress.

Nicola J Drummond, Nick O Davies, Janet E Lovett, Mark R Miller, Graeme Cook, Thomas Becker, Catherina G Becker, Donald B McPhail, Tilo Kunath

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Empowering Naringin's Anti-Inflammatory Effects through Nanoencapsulation.International journal of molecular sciences · 2024
    Article
  5. Review
  6. Anticancer Activity of Natural and Synthetic Chalcones.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Nicola J DrummondMRC Centre for Regenerative Medicine, Institute for Stem Cell Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH16 4UU, UK.
Nick O DaviesCentre for Neuroregeneration, Chancellor's Building, The University of Edinburgh, Edinburgh, EH16 4SB, UK.
Janet E LovettSUPA, School of Physics and Astronomy, University of St Andrews, North Haugh, St Andrews, KY16 9SS, UK.
Mark R MillerUniversity/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, EH16 4TJ, UK.
Graeme CookAntoxis Limited, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK.
Thomas BeckerCentre for Neuroregeneration, Chancellor's Building, The University of Edinburgh, Edinburgh, EH16 4SB, UK.
Catherina G BeckerCentre for Neuroregeneration, Chancellor's Building, The University of Edinburgh, Edinburgh, EH16 4SB, UK.
Donald B McPhailAntoxis Limited, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK.
Tilo KunathMRC Centre for Regenerative Medicine, Institute for Stem Cell Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH16 4UU, UK. tilo.kunath@ed.ac.uk.ORCID 0000-0002-8805-7356
University of Edinburgh · GBMRC Centre for Regenerative Medicine · GBUniversity of St Andrews · GB

Funding

British Heart Foundation SP/15/8/31575Medical Research Council MR/J012831/1Medical Research Council MR/K017047/1Medical Research Council MR/K017276/1
6 · The paper itself

Abstract

Excessive reactive oxygen species (ROS) can damage proteins, lipids, and DNA, which result in cell damage and death. The outcomes can be acute, as seen in stroke, or more chronic as observed in age-related diseases such as Parkinson's disease. Here we investigate the antioxidant ability of a novel synthetic flavonoid, Proxison (7-decyl-3-hydroxy-2-(3,4,5-trihydroxyphenyl)-4-chromenone), using a range of in vitro and in vivo approaches. We show that, while it has radical scavenging ability on par with other flavonoids in a cell-free system, Proxison is orders of magnitude more potent than natural flavonoids at protecting neural cells against oxidative stress and is capable of rescuing damaged cells. The unique combination of a lipophilic hydrocarbon tail with a modified polyphenolic head group promotes efficient cellular uptake and moderate mitochondrial enrichment of Proxison. Importantly, in vivo administration of Proxison demonstrated effective and well tolerated neuroprotection against cell loss in a zebrafish model of dopaminergic neurodegeneration.

Indexed as

FlavonoidsFree Radical ScavengersCell Line, TumorHumansNeuronsOxidative StressReactive Oxygen SpeciesFlavonoidsFree Radical ScavengersReactive Oxygen Species

Identifiers

PMID28928373
PMCPMC5605738
OpenAlexW2753241897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.